دورة المؤشرنت للتحليل الفني
50 دينار كويتي
تداول قوي في الافتتاح smmw
- بادئ الموضوع khalefa
- تاريخ البدء
صادق بس خففت الكمية خوف من التقسيم العكسي
شكرا لحرصك أخوي وهذا اللي محببني في المنتدى
حرصهم على بعض والجيب واحد
stockTrader
عضو نشط
- التسجيل
- 17 يوليو 2007
- المشاركات
- 22
الشركة عدد اسهمها بالهبل يعني بالمليارات === ومن مساوئ هذه الشركة بالذات انها بين الفتره والاخرى تصدر اسهم == ام بالنسبه الى رقم 0.0002 اعتقد ماراح توصله الا بمعجزه اذكر في السابق الفليوم تعدا المليار والسعر ثابت على رقم 0.0001 مما يعني ان عدد اسهمها كما ذكرنا بالهبل === فما بالك بفوليوم اليوم اللى هو 153.973.000 فقط ==
الشركه حصل لها إندماج عكسي
منقول من الاخ 5-50/5
--------------------------------------------------------------------------------
SMMW.PK
استحواذ الشركة على جميع ممتلكات وأنشطة شركة Pink Sheets:BPMT
SMMW (0.0001) Summus Works, Inc. Acquires Assets and Operations of BioPharmetics, Inc.
Monday, August 13 2007 7:59 AM, EST PrimeNewswire "PrimeNewswire "
SUN VALLEY, Calif., Aug. 13, 2007 (PRIME NEWSWIRE) -- Summus Works, Inc. (Pink Sheets:SMMW) announced the Company has successfully acquired substantially all the assets and business operations of BioPharmetics, Inc. (Pink Sheets:BPMT).
Three subsidiary divisions of BioPharmetics, Inc. provide quality durable medical equipment, diabetic supplies, and health, beauty, and anti-aging products to customer in the U.S., Canada , and over 23 countries throughout the world. The largest -- the pharmaceutical division -- distributes medical equipment and diabetes supplies, and dispenses physician-prescribed medications through its pharmacy partners. Additionally, the division works closely with a dealer network of health care companies and managed care facilities to provide superior pricing and customer support for Medicare, Medi-Cal, Medicaid and private insurance reimbursement programs.
The Biotechnology division is available for clients wanting to manufacture and test potential prescription medications and assist to facilitate the necessary FDA clinical trials in order to gain approval.
The cosmetic division manages the distribution of the TOMA line of cosmetics as well as private label manufacturing for companies seeking to enter the market place with their own formulations and ideas. BioPharmetics, Inc. was founded in 2005 and is headquartered in Sun Valley, CA.
The acquisition remains subject to the execution of definitive agreements and approvals. The closing date and further information will be released publicly.
For more information visit http://www.biopharmetics.com.
The BioPharmetics, Inc. logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=4096
The Summus Works, Inc. logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=4093
This release includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties including, but not limited to, the impact of competitive products, the ability to meet customer demand, the ability to manage growth, acquisitions of technology, equipment, or human resources, the effect of economic and business conditions, and the ability to attract and retain skilled personnel. The Company is not obligated to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.
CONTACT: Summus Works, Inc.
Dan Burgess
888-607-9495
summus@summusworks.com
منقول من الاخ 5-50/5
--------------------------------------------------------------------------------
SMMW.PK
استحواذ الشركة على جميع ممتلكات وأنشطة شركة Pink Sheets:BPMT
SMMW (0.0001) Summus Works, Inc. Acquires Assets and Operations of BioPharmetics, Inc.
Monday, August 13 2007 7:59 AM, EST PrimeNewswire "PrimeNewswire "
SUN VALLEY, Calif., Aug. 13, 2007 (PRIME NEWSWIRE) -- Summus Works, Inc. (Pink Sheets:SMMW) announced the Company has successfully acquired substantially all the assets and business operations of BioPharmetics, Inc. (Pink Sheets:BPMT).
Three subsidiary divisions of BioPharmetics, Inc. provide quality durable medical equipment, diabetic supplies, and health, beauty, and anti-aging products to customer in the U.S., Canada , and over 23 countries throughout the world. The largest -- the pharmaceutical division -- distributes medical equipment and diabetes supplies, and dispenses physician-prescribed medications through its pharmacy partners. Additionally, the division works closely with a dealer network of health care companies and managed care facilities to provide superior pricing and customer support for Medicare, Medi-Cal, Medicaid and private insurance reimbursement programs.
The Biotechnology division is available for clients wanting to manufacture and test potential prescription medications and assist to facilitate the necessary FDA clinical trials in order to gain approval.
The cosmetic division manages the distribution of the TOMA line of cosmetics as well as private label manufacturing for companies seeking to enter the market place with their own formulations and ideas. BioPharmetics, Inc. was founded in 2005 and is headquartered in Sun Valley, CA.
The acquisition remains subject to the execution of definitive agreements and approvals. The closing date and further information will be released publicly.
For more information visit http://www.biopharmetics.com.
The BioPharmetics, Inc. logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=4096
The Summus Works, Inc. logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=4093
This release includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties including, but not limited to, the impact of competitive products, the ability to meet customer demand, the ability to manage growth, acquisitions of technology, equipment, or human resources, the effect of economic and business conditions, and the ability to attract and retain skilled personnel. The Company is not obligated to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.
CONTACT: Summus Works, Inc.
Dan Burgess
888-607-9495
summus@summusworks.com
لافي العتيبي
عضو نشط
- التسجيل
- 21 أغسطس 2006
- المشاركات
- 563
شمعني الاندماج العكسي وهل هولصالح السهم ولا نبيع
لافي العتيبي
عضو نشط
- التسجيل
- 21 أغسطس 2006
- المشاركات
- 563
وصل 460 مليون
عصويد
عضو نشط
- التسجيل
- 10 يوليو 2006
- المشاركات
- 1,520
ابوليان مراقبه تنصح بدخول ممكن تفيدنا عن الخبرين الي نزلوا امس وشكرا
ابو ليان1
عضو نشط
- التسجيل
- 20 أغسطس 2006
- المشاركات
- 95
والله يا خوك ما اقدر انصحك او غيره
السهم شريته قبل ثمان اشهر
وتعرف اسهم البني ستوك ممكن في لحظه تقفز قفزات كبيره
وممكن تلقى رصيدك فيها صفر
انا شريت 5 مليون سهم بخمسمائة دولار ولا نبي فيه الكثير
ونقول يالله
دورة المؤشرنت للتحليل الفني
50 دينار كويتي